Crossmark

Should screening programs for carbapenemase-producing strains be implemented in ICU patients?

Crossref DOI link: https://doi.org/10.1016/j.eimce.2017.04.008

Published Print: 2017-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Oteo, Jesús
License Information

Text and Data Mining valid from 2017-06-01
More Information

This article is maintained by: Elsevier

Article Title: Should screening programs for carbapenemase-producing strains be implemented in ICU patients?

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2017.04.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2016.12.002

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.